IPA — IMMUNOPRECISE ANTIBODIES LTD
IPA (IMMUNOPRECISE ANTIBODIES LTD) is tracked on HoldingsHub across five years of quarterly 13F filings. 12 funds have reported positions historically, with the sum of their latest reported stakes valued at $824.11K. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Marshall Wace history | Q4 2021 | 83.38K | $447.00K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q1 2022 | 19.90K | $102.00K | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2025 | 90.86K | $96.31K | 0.00% | Hold |
| Citadel Advisors history | Q2 2025 | 59.50K | $63.07K | 0.00% | Add |
| Renaissance Technologies history | Q2 2025 | 40.48K | $42.91K | 0.00% | Add |
| Millennium Management history | Q4 2023 | 19.01K | $32.51K | 0.00% | New |
| Northern Trust Corp history | Q4 2024 | 41.11K | $16.92K | 0.00% | Reduce |
| Morgan Stanley history | Q2 2025 | 10.00K | $10.60K | 0.00% | Reduce |
| UBS Group AG history | Q2 2025 | 6.27K | $6.64K | 0.00% | Reduce |
| Geode Capital Management history | Q1 2025 | 10.67K | $4.02K | 0.00% | Hold |
| Bank of America Corp history | Q2 2025 | 2.01K | $2.13K | 0.00% | Hold |
| Citigroup Inc history | Q2 2025 | 7 | $7 | 0.00% | Hold |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 12 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Two Sigma Investments | 33.24K | — | — | — | — | — | — | — | — | — | — | — | — | — | 90.58K | 90.86K |
| Citadel Advisors | 173.70K | 177.37K | 318.50K | 394.66K | 325.66K | 327.72K | 381.61K | 276.68K | 241.98K | 302.33K | 26.60K | 26.08K | — | — | 27.20K | 59.50K |
| Renaissance Technologies | — | — | — | — | — | — | — | — | 14.60K | 23.00K | 37.60K | 63.91K | 60.30K | 78.20K | 29.40K | 40.48K |
| Morgan Stanley | 3.84K | 3.84K | 3.84K | 1.63K | 533 | 533 | 533 | 533 | 533 | 10.53K | 10.53K | 10.53K | 12.53K | 12.53K | 12.53K | 10.00K |
| UBS Group AG | 3.00K | 3.99K | — | 3.60K | 30 | 1.59K | — | — | 70 | 10.68K | 2.48K | 12.23K | — | — | 7.56K | 6.27K |
| Bank of America Corp | 1.50K | 2.95K | 57.52K | 2.60K | 2.00K | 2.00K | — | — | — | — | — | — | 2.00K | 2.00K | 2.00K | 2.01K |
| Citigroup Inc | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| JPMorgan Chase & Co | 53.72K | 60.12K | 19.90K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 14.50K | 17.48K | 17.48K | 17.48K | 17.48K | 17.48K | 17.48K | 17.48K | 17.48K | 17.48K | 17.48K | 17.48K | 17.48K | 10.67K | 10.67K | — |
| Marshall Wace | 175.51K | 83.38K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Millennium Management | — | — | — | — | — | — | — | — | — | 19.01K | — | — | — | — | — | — |
| Northern Trust Corp | — | — | — | — | — | — | — | — | — | 60.91K | 53.95K | 50.73K | 50.73K | 41.11K | — | — |